Form 4 for VRSN Verisign
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001624651-23-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-15 | 2023-02-14 | VRSN | Indelicarto Thomas C | EVP, Gen Counsel, Sec | S - Sale | $212.74 | -614 | 44.7K | -1% | -$130.6K | |
| 2023-02-15 | 2023-02-13 | VRSN | Indelicarto Thomas C | EVP, Gen Counsel, Sec | A - Grant | $0.00 | +7,516 | 45.3K | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | S | D | 614 | $212.74 | 44,694 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-13 | A | A | 7,516 | $0.00 | 45,308 | D | — | — | (F1) On February 13, 2023, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 25% on February 15, 2024 and ratably (6.25%) each of the following twelve quarters thereafter, subject to applicable taxes upon delivery. |